Project Grant R01MH143264
- Federal Grant Award Summary Vanderbilt University received a $106,092 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded August 11, 2026, with a completion date of August 7, 2029. This research initiative aims to enhance machine learning (ML) effectiveness in improving adherence to antiretroviral therapy (ART) among people living with HIV (PWH) through the application of synthetic data augmentation (SDA). The...
- Federal Grant Award Summary The University of South Carolina received a $631,513 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded February 15, 2026, with completion targeted for December 31, 2030. The project investigates modifiable factors affecting the HIV care continuum for people with HIV experiencing comorbid substance use and mental health conditions, with particular focus on social determinants of health...
- Federal Grant Award Summary The University of Florida Division of Sponsored Research received a $1.76 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Mental Health Research Grants program (CFDA 93.242), awarded April 1, 2026, with a completion date of December 31, 2030. The award funds development and implementation of the Synchronized Agentic Prescriptive System for Improving Sequentially HIV Care Continuum (SYNAPSIS-HIV-CC), a comprehensive artificial...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a $149,190 Project Grant on August 2, 2026, under the Mental Health Research Grants program (CFDA 93.242) to identify intervention opportunities in the continuum of cognitive impairment among persons aging with HIV. The research initiative delivers two primary analytical products: (1) population attributable fraction estimates for incident cognitive impairment cases attributable to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of North Carolina at Chapel Hill a Project Grant totaling $793,185 under the Mental Health Research Grants program (CFDA 93.242) on April 7, 2026. The award funds a four-year research initiative (through January 31, 2031) investigating the inactivation of the integrated stress response (ISR)/ATF4 signaling pathway as a novel strategy to stabilize and reduce Human Immunodeficiency Virus (HIV)...
- Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1.81 million Project Grant (CFDA 93.242 – Mental Health Research Grants) to the University of Alabama at Birmingham on June 5, 2026, for a two-year project period through June 4, 2028. The grant supports the development of novel preclinical models of neuroHIV (HIV-associated central nervous system dysfunction) that incorporate chimeric antigen receptor T cell (CAR-T) technology. Specifically, the research aims to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $722,773 Project Grant to The Leland Stanford Junior University on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support research on explainable artificial intelligence (XAI) for predicting depression in people with HIV (PWH). The project, scheduled for completion by March 31, 2031, addresses the critical clinical need to improve depression identification and management in...
- Federal Grant Award Summary The University of South Carolina received a $163,395 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 15, 2026, with a completion date of June 14, 2028. This research initiative addresses sensory processing difficulties in individuals with autism spectrum disorder (ASD) by developing novel physiological measures of sensory reactivity in early infancy. The primary deliverable...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Southern California a $654,923 Project Grant (CFDA 93.242 – Mental Health Research Grants) commencing September 1, 2025, through June 30, 2030, to establish and disseminate CentileBrain, a normative modeling framework for brain health and disease. This international initiative, spearheaded by the ENIGMA (Enhancing Neuroim Genetics through Meta-Analysis) Consortium, addresses a critical gap in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Trustees of the University of Pennsylvania a $500,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 18, 2026, with an ultimate completion date of February 28, 2031. The project, "Advancing Multimodal Artificial Intelligence/Machine Learning to Enhance HIV Clinical Care," develops novel multimodal artificial intelligence and machine learning (AI/ML) models that...
The University of South Carolina received a $1,016,319 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2026, with completion targeted for April 30, 2031. The project, titled "Multimodal AI for Monitoring and Predicting Neurocognitive Impairment in People with HIV," will develop and apply artificial intelligence methodologies to advance precision medicine approaches for HIV-associated neurocognitive disorders (HAND). The research will leverage the All of Us Research Program, a centralized NIH data repository providing secure access to de-identified multimodal data including electronic health records, genomic information, survey responses, and imaging data from nearly one million participants, including over 6,600 individuals with confirmed HIV infection identified through computational phenotyping. The grant deliverables will focus on creating integrated machine learning and deep learning models that combine multiple data modalities to improve the diagnostic accuracy and prognostic capability of existing neurocognitive impairment assessment tools. Current clinical approaches remain limited by siloed, unimodal datasets; this project will address that gap by developing multimodal artificial intelligence methodologies that leverage complementary information across data types to enhance real-time monitoring and clinical decision-making for the nearly half of people with HIV who experience asymptomatic neurocognitive disorder or mild neurocognitive disorder despite advances in antiretroviral therapy.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.0m | 7/6/26 |